More Equitable Solution Than LLINs in Senegal

Malaria continues to be one of the most significant public health challenges in West Africa despite decades of interventions, research, and strategic investments. Senegal, a regional leader in malaria control, has made remarkable progress—reducing malaria incidence from over 300 cases per 1,000 people at risk in 2000 to around 50 cases in 2020. Yet, the disease remains endemic, and every citizen continues to face some degree of exposure.

As we assess the evolving landscape of malaria interventions, it is increasingly clear that Seasonal Malaria Chemoprophylaxis (SMC) represents a highly equitable, targeted, and effective strategy, especially when compared to Long-Lasting Insecticide-Treated Nets (LLINs). Through years of implementation, Senegal’s expanded SMC program—unique in Africa—has demonstrated that door-to-door chemoprevention can reach more children and close critical coverage gaps more effectively than traditional LLIN distribution alone.

This article presents a comprehensive analysis of how SMC is shaping malaria prevention in Senegal, why its model stands out globally, and why expanding SMC could ultimately bring communities closer to malaria elimination.


Understanding Senegal’s Malaria Transmission Zones

Senegal’s geography creates two distinct malaria transmission zones that determine national prevention strategies:

1. The Tropical Southern Zone (Year-Round Transmission)

  • Warm, humid climate creates continuous mosquito breeding.
  • High malaria exposure for most of the year.
  • Requires layered prevention including LLINs, Indoor Residual Spraying (IRS), and diagnostics.

2. The Sahelian Northern Zone (Seasonal Transmission)

  • Malaria spikes during and immediately after the rainy season (typically 4 months).
  • Over 60%–80% of annual malaria cases occur in this short window.
  • Ideal for SMC, which is designed for predictable seasonal malaria surges.

The national malaria strategy must therefore remain flexible and context-specific. As data over the past decade show, SMC has emerged as one of the most powerful tools in areas with high seasonal transmission, substantially decreasing malaria hospitalizations and mortality rates among children.


Why SMC Remains Critical for Senegal’s Malaria Control Success

SMC: A Preventive Treatment That Saves Lives

The WHO recommends SMC for:

  • Children aged 3–59 months
  • In countries where seasonal malaria peaks sharply in a few months

Senegal goes further—extending SMC to children up to 10 years old, recognizing the unique epidemiology of its northern region. This bold decision immediately improved protection for school-age children who traditionally fall outside typical malaria prevention programs.

Medications Used in SMC

Each SMC cycle includes:

  • Amodiaquine (AQ) – 1 tablet under supervision
  • Sulfadoxine-Pyrimethamine (SP) – 3 tablets (first supervised, remaining two taken at home)

This combination provides high-level prophylaxis for 28–30 days, making it ideal for recurring monthly rounds.


A Community-Led Model With Proven Impact

Before WHO endorsed SMC in 2012, there were doubts about feasibility:

  • Could community health workers execute repeated house-to-house sweeps?
  • Would caregivers administer doses correctly?
  • Could a door-to-door model maintain high coverage?

Senegal proved not only that SMC delivery is feasible on a large scale, but that it can be one of the most equitable malaria interventions ever implemented.

Key Findings From Senegal’s SMC Implementation

  • Coverage rates exceeded those of LLIN use in the same districts.
  • Door-to-door delivery improved reach in remote and low-income households.
  • Children over five years were successfully reached, demonstrating adaptability and community acceptance.
  • Equity gaps were narrower under SMC than under LLIN distribution, which often favors more accessible or wealthier households.

This model has since influenced discussions across malaria-endemic countries about expanding SMC to older children and adopting house-to-house delivery for more equitable health outcomes.


Why SMC Is More Equitable Than LLINs

1. Direct Delivery Eliminates Barriers

While LLIN distribution campaigns rely on households visiting collection points, SMC involves CHWs visiting every household, reducing:

  • Transport barriers
  • Awareness gaps
  • Participation drop-off

This ensures maximum coverage, especially for vulnerable or marginalized families.

2. Community Health Workers Build Trust

The CHW network is the backbone of malaria prevention in Senegal. Their personal engagement:

  • Ensures proper dosing
  • Reinforces health education
  • Encourages adherence

This human-centered approach is more effective than distributing nets alone.

3. SMC Reaches Older Children

LLIN campaigns often overlook the reality that children aged 5–10 are frequently exposed outdoors, especially during school hours or play.
Senegal’s decision to include this age group:

  • Reduces community parasite reservoirs
  • Protects schoolchildren
  • Supports broader herd-protection effects

4. High Adherence and Consistent Coverage

Four to five monthly visits ensure systematic protection during peak season. LLINs, however, depend on:

  • Consistent nightly use
  • Proper net maintenance
  • Household behavior patterns

SMC offers a controlled and reliable intervention, ensuring uniform protection.


Role of PMI and the Need for Shared Global Investment

At present, the U.S. President’s Malaria Initiative (PMI) is the sole financial supporter of SMC in Senegal. They provide:

  • Planning and logistics support
  • Training for nurses and CHWs
  • Procurement of AQ and SP medications
  • Implementation monitoring

While this has driven remarkable success, expanded donor support is essential. Stakeholders such as:

  • The Global Fund
  • National governments
  • WHO
  • Bilateral health partners

can contribute to scaling SMC to additional regions and sustaining long-term malaria control.

Integrating SMC with LLIN distribution, IRS, and diagnostics creates a multi-layered shield that reduces transmission and accelerates progress toward elimination.


Future Directions: Strengthening the SMC Ecosystem Across Africa

Senegal’s experience provides a roadmap for other malaria-endemic countries:

1. Adopt Door-to-Door SMC Distribution

Evidence overwhelmingly shows higher coverage and equity compared to fixed-site distribution.

2. Expand SMC Eligibility to Older Children

School-age children significantly contribute to malaria transmission reservoirs. Expanding coverage could further reduce community-wide incidence.

3. Invest in CHW Capacity Building

Training, certification, and financial incentives for CHWs ensure long-term sustainability.

4. Integrate SMC Data Into National Surveillance Systems

Real-time data enhances:

  • Outbreak prediction
  • Resource allocation
  • Program accountability

5. Mobilize Multisectoral Funding

Combining efforts from health partners, government bodies, and NGOs will accelerate SMC growth.


Seasonal Malaria Chemoprophylaxis stands as one of the most equitable, impactful, and scientifically validated malaria prevention strategies in Senegal. Its success is a testament to community-driven health models, evidence-based policymaking, and innovative program expansion to protect school-age children. While LLINs remain a cornerstone of malaria prevention, SMC has proven that tailored, door-to-door interventions can bridge coverage gaps and ensure that every child—regardless of income, location, or background—receives life-saving protection.

For sustained progress, international partners and local governments must continue expanding SMC coverage, investing in CHWs, and strengthening health systems. With continued commitment, Senegal’s pathway can serve as a model for malaria-endemic regions across Africa, bringing the continent closer to a malaria-free future.